Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition

Pioglitazone (PIO) is an insulin-sensitizing antidiabetic drug, which normalizes glucose and lipid metabolism but may provoke heart and liver failure and chronic kidney diseases. Both therapeutic and adverse effects of PIO can be accomplished through mitochondrial targets. Here, we explored the capa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ekaterina S. Kharechkina (Author), Anna B. Nikiforova (Author), Konstantin N. Belosludtsev (Author), Tatyana I. Rokitskaya (Author), Yuri N. Antonenko (Author), Alexey G. Kruglov (Author)
Formato: Livro
Publicado em: MDPI AG, 2021-10-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível